Association of proton-pump inhibitors with outcomes inClostridium difficilecolitis
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 64 (22) , 2359-2363
- https://doi.org/10.2146/ajhp060629
Abstract
Purpose. The role of concurrent use of proton-pump inhibitors (PPIs) in the outcomes of treatment for Clostridium difficile colitis was studied.Keywords
This publication has 17 references indexed in Scilit:
- Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanideJournal of Antimicrobial Chemotherapy, 2007
- Nitazoxanide for the Treatment of Clostridium difficile ColitisClinical Infectious Diseases, 2006
- An Update on Diagnosis, Treatment, and Prevention of Clostridium difficile–Associated DiseaseGastroenterology Clinics of North America, 2006
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Albumin, length of stay, and proton pump inhibitors: Key factors in Clostridium difficile-associated disease in nursing home patientsJournal of the American Medical Directors Association, 2005
- Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studiesCMAJ : Canadian Medical Association Journal, 2004
- Occurrence and significance of gastric colonization during acid-inhibitory therapyBest Practice & Research Clinical Gastroenterology, 2001
- Treatment of Antibiotic-Associated Pseudomembranous ColitisClinical Infectious Diseases, 1984
- Treatment of Clostridium difficile colitis and diarrhea with vancomycinThe American Journal of Medicine, 1981